Revive Provides Dial-In Information for Annual and Special Meeting

    NEXT STORY
    Study Identifies New Role of BioAegis’ ‘Inflammation Regulator’ Gelsolin Relevant for a Range of Inflammatory Diseases
    PREV STORY
    10x Genomics to Report First Quarter Financial Results on May 5, 2021
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Trillium Announces Pricing of US$15 Million Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units

    author_avatar
    NASDAQ Market News

    Akcea and Ionis Report Top-line Results from the BROADEN Study with WAYLIVRA® (volanesorsen) in Patients with Familial Partial Lipodystrophy

    author_avatar
    NASDAQ Market News

    Genenta Appoints Four Renowned Oncology Experts to Scientific Advisory Board

    author_avatar
    NASDAQ Market News